Combination therapy with peptide epoxyketones
USRE47954E1 · kind E1 · reissue
0Cited by
76References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 2017 |
| Grant date | Apr 21, 2020 |
| Priority date | — |
| Expiry date | Jun 30, 2037 |
Classification
- Technology area (CPC —)General
Abstract
ABSTRACT The invention provides combination therapy, wherein one or more other therapeutic agents are administered agents are administered with peptide epoxyketones or a pharmaceutically acceptable salt thereof. Another aspect of the invention relates to treating cancer with a peptide epoxyketone administered in combination with another therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.